Viral Hepatitis Flashcards
Three main clinical presentations of Hepatitis
1) Acute
2) Chronic
3) Fulminant
Acute Viral Hepatitis Symptoms
1) Jaundice
2) Dark Urine
3) Acholic stool (light or clay-colored due to reduced bile production)
4) Prodrome (1-2 weeks prior to jaundice; Headache, myalgias, arthralgias, fatigue, nausea, vomiting, pharyngitis, mild fever)
Acute Viral Hepatitis Biochemistry
1) Bilirubin Levels
>3 mg/dL Jaundice
Commonly 5-20 mg/dL
Bilirubin in urine = liver disease
2) Liver Enzymes
- Alanine aminotransferase (ALT)
- Aspartate aminotransferase (AST)
- Elevation apparent as early as PRODROME PHASE
- Usually higher than that of other hepatitis causes
- May be up to 1000 U/L-ALT
Chronic Viral Hepatitis
- Hepatitis which DOES NOT resolve within 6 months
- Predisposes to hepatocellular carcinoma and cirrhosis
Fulminant Viral Hepatitis
- RAPID, SEVERE hepatitis
- Massive hepatic NECROSIS
- Encephalopathy (CNS EFFECTS): confusion, disorientation, coma
- Edema
- Complications: cerebral edema, brainstem compression, GI bleeding, sepsis, organ failure
- LIVER TRANSPLANT can be lifesaving
Hepatitis A (Virus Family, Transmission, Chronic Infection)
Picornavirus, Fecal-Oral, No
Hepatitis B (Virus Family, Transmission, Chronic Infection)
Hepadnavirus, Body Fluids, Yes
Hepatitis C (Virus Family, Transmission, Chronic Infection)
Flavivirus, Body Fluids, Yes
Hepatitis D (Virus Family, Transmission, Chronic Infection)
Deltavirus, Body Fluids, Yes
Hepatitis E (Virus Family, Transmission, Chronic Infection)
Hepevirus, Fecal-Oral, No
Hepatitis A
Picornavirus Family \+ssRNA Fecal oral transmission Seroprevalence 30% All age groups susceptible, children usually ASYMPTOMATIC Incubation period ~28 days Resolution usually within 2 months ***DOES NOT cause chronic hepatitis*** Very rarely causes fulminant hepatitis
Hepatitis A (Diagnosis)
Acute Infection = IgM antibodies against HAV
Anti-HAV IgG antibodies protective immunity (will be present in patients who were PREVIOUSLY exposed)
Hepatitis A (Prevention)
- HAVRIX and VAQTA
- IM injection (2 dose schedule)
- Since 2005, ACIP recommends universal vaccination for all infants (12-23 months), as well as high risk adult groups
- Post-exposure Prophylaxis* (Vaccine or anti-HAV IgG antibodies)
Hepatitis B (Appearance)
Tubes and Spheres: Incomplete, Noninfectious particles (Hepatitis B Surface Antigen - HBsAg)
Dane Particles: Complete Virions (HBsAg, Hepatitis B Core Antigen - HBcAg, and HBeAg)
Hepatitis B (Characteristics)
Hepadnavirus Family
Partially dsDNA genome
REVERSE TRANSCRIPTION (via reverse transcriptase) is part of life cycle
NOT a Retrovirus
Hepatitis B (Acute vs Chronic)
Acute:
- HBsAg is cleared PRIOR TO 6 months
- After this will see Anti-HBs
- Early–> will see IgM
- Late–> will see IgG
Chronic:
- HBsAg is maintained for a long period of time
- **DO NOT have Anti-HBs in this type because it is seen in RECOVERY and you are not having recovery in chronic infections
Hepatitis B (Diagnosis)
- Viral antigens and anti-HBV antibodies used for diagnosis
- Presence of HBsAg within the blood is a marker of ACTIVE INFECTION
Hepatitis B (Acute vs Chronic Lab Tests)
Acute: Anti-HBc Total and IgM are POSITIVE
Chronic: Anti-HBc Total is POSITIVE and IgM is NEGATIVE
How do you know if a patient is susceptible to HBV?
They will have a NEGATIVE Anti-HBc Total test
How do you know if a patient has been previously infected with HBV?
Positive Anti-HBsAg and Positive Anti-HBc Total test
How do you know if a patient has been vaccinated against HBV?
Will have Positive Anti-HBsAg
Hepatitis B (Characteristics)
- Incubation period median 90 days
- Transmission route = Bodily Fluids (e.g. sexual transmission, percutaneous needle stick (6-30%), perinatal transmission at birth (10-90%)
- Half of infected adults are ASYMPTOMATIC
- Acute symptoms are often MILDER than HAV
Younger you are, the more likely you are to develop a chronic HBV infection
Birth = 90% ; Over 5 years old = 10%
Hepatitis B (Treatment)
- None for acute infections
-
Chronic infections
a) Lamivudine —> REVERSE TRANSCRIPTION INHIBITOR
b) Famcyclovir/Adefovir dipivoxil: NUCLEOSIDE INHIBITOR
c) Interferon alpha
Usually a combo of either A and C or B and C
Hepatitis B (Vaccine)
IM injection - 3 dose schedule
Currently use Recombinant HBV vaccine produce in YEAST CELLS (Recombinvax HB and Engerix B)
-Recommended for all infants (1st dose soon after delivery)